COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,722 Articles (22,913 medRxiv, 8,809 bioRxiv)

Most recent first Previous |  Page 3005: Articles 30041-30050  | Next

Estimating the real-time case fatality rate of COVID-19 using Poisson mixtures model
Lee, P. H.
10.1101/2020.04.11.20062190 — Posted: 2020-04-15
Intervention strategies against COVID-19 and their estimated impact on Swedish healthcare capacity
Gardner, J. M., Willem, L., van der Wijngaart, W., Kamerlin, S. C. L., Brusselaers, N., Kasson, P.
10.1101/2020.04.11.20062133 — Posted: 2020-04-15 Discussion: Onsite
Human agency and infection rates: implications for social distancing during epidemics
Bronk Ramsey, C.
10.1101/2020.04.11.20062042 — Posted: 2020-04-15
Epidemiological investigation and intergenerational clinical characteristics of 24 COVID-19 patients associated with supermarket cluster
Tian, S., Wu, M., Chang, Z., Wang, Y., Zhou, G., Zhang, W., Xing, J., Tian, H., Zhang, X., Zou, X., Zhang, L., Liu, M., Chen, J., Han, J., Ning, K., Chen, S., Wu, T.
10.1101/2020.04.11.20058891 — Posted: 2020-04-15 Discussion: Onsite
Effect of various decontamination procedures on disposable N95 mask integrity and SARS-CoV-2 infectivity
Smith, J. S., Hanseler, H., Welle, J., Rattray, R., Campbell, M., Brotherton, T., Moudgil, T., Pack, T. F., Wegmann, K., Jensen, S., Jin, J. S., Bifulco, C. B., Fox, B. A., Stucky, N. L.
10.1101/2020.04.11.20062331 — Posted: 2020-04-15 Discussion: Onsite
The clinical characteristics and mortal causes analysis of COVID-19 death patients
Guo, A.-X., Cui, J.-J., OuYang, Q.-Y., He, L., Guo, C.-X., Yin, J.-Y.
10.1101/2020.04.12.20062380 — Posted: 2020-04-15
Rapid diagnosis of SARS-CoV-2 infection by detecting IgG and IgM antibodies with an immunochromatographic device: a prospective single-center study
Garcia, F. P., Perez Tanoira, R., Romanyk Cabrera, J. P., Arroyo Serrano, T., Gomez Herruz, P., Cuadros Gonzalez, J.
10.1101/2020.04.11.20062158 — Posted: 2020-04-15
Assessment of N95 respirator decontamination and re-use for SARS-CoV-2
Fischer, R., Morris, D. H., van Doremalen, N., Sarchette, S., Matson, J., Bushmaker, T., Yinda, C. K., Seifert, S., Gamble, A., Williamson, B., Judson, S., de Wit, E., Lloyd-Smith, J., Munster, V.
10.1101/2020.04.11.20062018 — Posted: 2020-04-15 Discussion: Onsite
Delayed-Phase Thrombocytopenia in Patients of Coronavirus Disease 2019 (COVID-19)
Zhou, H., Chen, W., Li, Z., Yang, B., Zhou, Q., Wang, P., Zhu, J., Chen, X., Yang, P.
10.1101/2020.04.11.20059170 — Posted: 2020-04-15
De novo 3D models of SARS-CoV-2 RNA elements and small-molecule-binding RNAs to guide drug discovery
Rangan, R., Watkins, A. M., Kladwang, W., Das, R.
10.1101/2020.04.14.041962 — Posted: 2020-04-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).